About Bioverge
Bioverge is a company based in San Francisco (United States) founded in 2016 by Neil Littman. The company has 2 employees as of December 31, 2022. Bioverge offers products and services including Bioverge Access Fund, Deal-By-Deal Investing, and Thematic Funds. Bioverge operates in a competitive market with competitors including Healthcare Shares, Sana Capital, BioVentureOne, KTR Capital and Bioverge Portal, among others.
- Headquarter San Francisco, United States
- Employees 2 as on 31 Dec, 2022
- Founders Neil Littman
-
Sectors
Technology
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Bioverge, Inc.
-
Annual Revenue
$136.25 K (USD)-45as on Apr 29, 2024
-
Net Profit
-$431.3 K (USD)-6as on Apr 29, 2024
-
EBITDA
Not available
-
Latest Funding Round
Not available
-
Investors
Not available
-
Employee Count
2
as on Dec 31, 2022
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Bioverge
Bioverge offers a comprehensive portfolio of products and services, including Bioverge Access Fund, Deal-By-Deal Investing, and Thematic Funds.
Diversified portfolio for healthcare startup investments
Select individual opportunities in healthcare ventures
Focus on areas like cancer and digital health investing
Funding Insights of Bioverge
Detailed funding history for Bioverge
Round names, dates, amounts, investors, and valuation history require an active premium plan.
- Round names and dates
- Funding amounts
- Participating investors
- Valuation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Bioverge
Investment portfolio details for Bioverge
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Bioverge
Detailed financials for Bioverge
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Bioverge Comparisons
Peer comparison for Bioverge
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Bioverge
Bioverge operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Healthcare Shares, Sana Capital, BioVentureOne, KTR Capital and Bioverge Portal, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Crowdfunding is enabled for healthcare ventures and initiatives.
|
|
| Locked | Locked | Locked |
Early-stage fund investing in healthcare services and technology.
|
|
| Locked | Locked | Locked |
Serves as a fundraising platform for life sciences and healthcare ventures.
|
|
| Locked | Locked | Locked |
Offers AI-powered wealth management, hedge funds, and trading solutions for clients.
|
|
| Locked | Locked | Locked |
An alternative investment platform focused on funding healthcare startups.
|
Detailed competitors of Bioverge
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Bioverge
Complete news archive for Bioverge
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Bioverge
Bioverge was founded in 2016.
Bioverge is headquartered in San Francisco, United States. It is registered at San Francisco, California, United States.
Neil Littman is the current CEO of Bioverge. They have also founded this company.
As of Dec 31, 2022, the latest employee count at Bioverge is 2.
Annual revenue of Bioverge is $136.25K as on Apr 29, 2024.
Bioverge was founded in 2016 in San Francisco, United States, as an alternative investment platform focused on healthcare startups. Investments in individual startups or Bioverge-managed funds are facilitated for users. Outside funding opportunities from third parties are provided, alongside quality screening processes to evaluate potential investments. Operations center on connecting investors with vetted healthcare sector opportunities.
Bioverge's top competitors include Healthcare Shares, Sana Capital and BioVentureOne.
Bioverge offers Bioverge Access Fund, Deal-By-Deal Investing, and Thematic Funds.